摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Bromo-N-cyclohexyl-N-methyl-acetamide | 883521-20-8

中文名称
——
中文别名
——
英文名称
2-Bromo-N-cyclohexyl-N-methyl-acetamide
英文别名
2-bromo-N-cyclohexyl-N-methylacetamide
2-Bromo-N-cyclohexyl-N-methyl-acetamide化学式
CAS
883521-20-8
化学式
C9H16BrNO
mdl
——
分子量
234.136
InChiKey
GVHBGCPNPJQNJP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    2-Bromo-N-cyclohexyl-N-methyl-acetamide 在 N,N'-ditosylhydrazine 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 以54%的产率得到N-cyclohexyl-2-diazo-N-methylacetamide
    参考文献:
    名称:
    通过Ru(II)-Pheox催化的区域选择性分子内Csp 3 -H插入重氮乙酰胺合成γ-内酰胺
    摘要:
    在此,以高收率得到γ-内酰胺衍生物通过高度选择性分子内CSP 3通过催化α-diazoacetamides的-H插入反应外消旋-Ru(II)-Pheox复杂。该催化体系可在温和条件下应用于各种重氮乙酰胺,以生产相应的γ-内酰胺。
    DOI:
    10.1016/j.tetlet.2020.152276
  • 作为产物:
    描述:
    N-甲基环己胺溴乙酰溴potassium carbonate 作用下, 以 二氯甲烷 为溶剂, 反应 3.0h, 生成 2-Bromo-N-cyclohexyl-N-methyl-acetamide
    参考文献:
    名称:
    通过Ru(II)-Pheox催化的区域选择性分子内Csp 3 -H插入重氮乙酰胺合成γ-内酰胺
    摘要:
    在此,以高收率得到γ-内酰胺衍生物通过高度选择性分子内CSP 3通过催化α-diazoacetamides的-H插入反应外消旋-Ru(II)-Pheox复杂。该催化体系可在温和条件下应用于各种重氮乙酰胺,以生产相应的γ-内酰胺。
    DOI:
    10.1016/j.tetlet.2020.152276
点击查看最新优质反应信息

文献信息

  • 1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity
    作者:Fernanda Souza Macchi、Kenia Pissinate、Anne Drumond Villela、Bruno Lopes Abbadi、Valnês Rodrigues-Junior、Débora Dreher Nabinger、Stefani Altenhofen、Nathalia Sperotto、Adílio da Silva Dadda、Fernanda Teixeira Subtil、Talita Freitas de Freitas、Ana Paula Erhart Rauber、Ana Flávia Borsoi、Carla Denise Bonan、Cristiano Valim Bizarro、Luiz Augusto Basso、Diógenes Santiago Santos、Pablo Machado
    DOI:10.1016/j.ejmech.2018.06.005
    日期:2018.7
    zebrafish (Danio rerio) toxicity models. 3,4-Dihydroquinazolin-4-ones 9q and 9w were considered the lead compounds of these series of molecules with MIC values of 0.24 μM and 0.94 μM against M. tuberculosis H37Rv, respectively. Taken together, these data indicate that this class of compounds may furnish candidates for future development of novel anti-TB drugs.
    使用经典的杂交方法,合成了一系列1 H-苯并[ d ]咪唑和3,4-二氢喹唑啉-4-酮(39个实例),并被评估为结核分枝杆菌生长的抑制剂。化学修饰研究产生了有效的抗结核药,对结核分枝杆菌H37Rv菌株的最低抑菌浓度(MIC)值低至0.24μM。此外,合成的化合物对一线药物具有四个不同耐药水平的四个耐药菌株具有活性。这些分子对带有IC 50s的HepG2,HaCat和Vero细胞无明显毒性 > 30μM。使用MTT和中性红分析评估了哺乳动物细胞培养物中的生存力。此外,一些3,4-二氢喹唑啉-4-酮表现出心脏毒性,在斑马鱼中没有神经毒性或形态学改变的信号(低风险斑马鱼)毒性的模型。3,4-二氢喹唑啉-4-酮9q和9w被认为是该系列分子中针对结核分枝杆菌H37Rv的MIC值为0.24μM和0.94μM的先导化合物。综合来看,这些数据表明这类化合物可为新型抗结核药物的未来开发提供候选。
  • 10.1080/14756366.2024.2388207
    作者:Czeczot, Alexia de Matos、Muniz, Mauro Neves、Perelló, Marcia Alberton、Silva, Éverton Edésio Dinis、Timmers, Luís Fernando Saraiva Macedo、Berger, Andresa、Gonzalez, Laura Calle、Arraché Gonçalves, Guilherme、Moura, Sidnei、Machado, Pablo、Bizarro, Cristiano Valim、Basso, Luiz Augusto
    DOI:10.1080/14756366.2024.2388207
    日期:——
    The crystallographic structure of the FolB enzyme from Mycobacterium tuberculosis (MtFolB), complexed with its inhibitor 8-mercaptoguanine (8-MG), was elucidated at a resolution of 1.95 Å. A novel ...
    结核分枝杆菌 (MtFolB) 的 FolB 酶与其抑制剂 8-巯基鸟嘌呤 (8-MG) 复合的晶体结构以 1.95 Å 的分辨率得以阐明。一本小说...
  • Synthesis and NK1/NK2 receptor activity of substituted-4(Z)-(methoxyimino)pentyl-1-piperazines
    作者:Pauline C Ting、Joe F Lee、John C Anthes、Neng-Yang Shih、John J Piwinski
    DOI:10.1016/s0960-894x(00)00464-9
    日期:2000.10
    A series of 5-[(3,5-bis(trifluoromethyl)phenyl)methoxy]3-(3,4-dichlorophenyl)-4(Z)-(methoxyimino)pentyl-1-piperazines was prepared and their affinity for the NK1 and NK2 receptors investigated. Compounds 7f: 10o, 10r, and 10s were found to be our most potent inhibitors. (C) 2000 Elsevier Science Ltd. All rights reserved.
  • 2,4-Diarylpyrrolidine-3-carboxylic AcidsPotent ET<sub>A</sub> Selective Endothelin Receptor Antagonists. 1. Discovery of A-127722
    作者:Martin Winn、Thomas W. von Geldern、Terry J. Opgenorth、Hwan-Soo Jae、Andrew S. Tasker、Steven A. Boyd、Jeffrey A. Kester、Robert A. Mantei、Radhika Bal、Bryan K. Sorensen、Jinshyun R. Wu-Wong、William J. Chiou、Douglas B. Dixon、Eugene I. Novosad、Lisa Hernandez、Kennan C. Marsh
    DOI:10.1021/jm9505369
    日期:1996.1.1
    We have discovered a novel class of endothelin (ET) receptor antagonists through pharmacophore analysis of the existing non-peptide ET antagonists. On the basis of this analysis, we determined that a pyrrolidine ring might replace the indan ring in SE 209670. The resultant compounds were readily prepared and amenable to extensive SAR studies. Thus a series of N-substituted trans,trans-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl) pyrrolidine-3-carboxylic acids (8) have been synthesized and evaluated for binding at ET(A) and ET(B) receptors. Compounds with N-acyl and simple N-alkyl substituents had weak activity. Compounds with N-alkyl substituents containing ethers, sulfoxides, or sulfones showed increased activity. Much improved activity resulted from compounds where the N-substituents were acetamides. Compound 17u (A-127722) with the N,N-dibutylacetamide substituent is the best of the series. It has an IC50 = 0.36 nM for inhibition of ET-1 radioligand binding at the ETA(A) receptor, with a 1000-fold selectivity for the ET(A) vs the ET(B) receptor. It is also a potent inhibitor (IC50 = 0.16 nM) of phosphoinositol hydrolysis stimulated by ET-1, and it antagonized the ET-l-induced contraction of the rabbit aorta with a pA(2) = 9.20. The compound has 70% oral bioavailability in rats.
  • Synthesis of γ-lactams via Ru(II)–Pheox-catalyzed regioselective intramolecular Csp3–H insertion of diazoacetamides
    作者:Takuji Fujii、Huong Dang Thi Thu、Seiji Iwasa
    DOI:10.1016/j.tetlet.2020.152276
    日期:2020.9
    Herein, γ-lactam derivatives are obtained in high yield via highly regioselective intramolecular Csp3–H insertion reactions of α-diazoacetamides catalyzed by a rac-Ru(II)–Pheox complex. The catalytic system is applicable to a wide range of diazoacetamides under mild conditions to produce the corresponding γ-lactams.
    在此,以高收率得到γ-内酰胺衍生物通过高度选择性分子内CSP 3通过催化α-diazoacetamides的-H插入反应外消旋-Ru(II)-Pheox复杂。该催化体系可在温和条件下应用于各种重氮乙酰胺,以生产相应的γ-内酰胺。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物